Xiaoli Cheng

Person

Mountain View, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions of peptide inhibitors of Interleukin-23 receptor
- Patent number 11,939,361
- Issue date Mar 26, 2024
- JANSSEN PHARMACEUTICA NV
- Giustino Di Pretoro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral peptide inhibitors of interleukin-23 receptor and their use to...
- Patent number 11,884,748
- Issue date Jan 30, 2024
- Protagonist Therapeutics, Inc.
- Ashok Bhandari
- G01 - MEASURING TESTING
Information Patent Grant
Oral peptide inhibitors of interleukin-23 receptor and their use to...
- Patent number 10,941,183
- Issue date Mar 9, 2021
- Protagonist Therapeutics, Inc.
- Ashok Bhandari
- G01 - MEASURING TESTING
Information Patent Grant
Peptide inhibitors of interleukin-23 receptor and their use to trea...
- Patent number 10,787,490
- Issue date Sep 29, 2020
- Protaganist Therapeutics, Inc.
- Ashok Bhandari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral peptide inhibitors of interleukin-23 receptor and their use to...
- Patent number 10,196,424
- Issue date Feb 5, 2019
- Protagonist Therapeutics, Inc.
- Gregory Bourne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oral peptide inhibitors of interleukin-23 receptor and their use to...
- Patent number 10,035,824
- Issue date Jul 31, 2018
- Protagonist Therapeutics, Inc.
- Ashok Bhandari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral peptide inhibitors of interleukin-23 receptor and their use to...
- Patent number 10,023,614
- Issue date Jul 17, 2018
- Protagonist Therapeutics, Inc.
- Ashok Bhandari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral peptide inhibitors of interleukin-23 receptor and their use to...
- Patent number 9,624,268
- Issue date Apr 18, 2017
- Protagonist Therapeutics, Inc.
- Gregory Thomas Bourne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS OF PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR
- Publication number 20240254180
- Publication date Aug 1, 2024
- Janssen Pharmaceutica N.V.
- Giustino DI PRETORO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...
- Publication number 20240199700
- Publication date Jun 20, 2024
- Protagonist Therapeutics, Inc.
- Ashok BHANDARI
- G01 - MEASURING TESTING
Information Patent Application
Methods for Treating Inflammatory Bowel Diseases with alpha4beta7 I...
- Publication number 20230063321
- Publication date Mar 2, 2023
- Protagonist Therapeutics, Inc.
- Suneel Kumar Gupta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...
- Publication number 20210363185
- Publication date Nov 25, 2021
- Protagonist Therapeutics, Inc.
- Ashok Bhandari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...
- Publication number 20190337983
- Publication date Nov 7, 2019
- Protagonist Therapeutics, Inc.
- Ashok Bhandari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREA...
- Publication number 20190300590
- Publication date Oct 3, 2019
- Protagonist Therapeutics, Inc.
- Ashok BHANDARI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PEPTIDE INHIBITORS OF INTERLEUKIN-23 AND THEIR USE TO TREAT INFLAMM...
- Publication number 20190270786
- Publication date Sep 5, 2019
- Protagonist Therapeutics, Inc.
- Ashok BHANDARI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...
- Publication number 20180079783
- Publication date Mar 22, 2018
- Protagonist Therapeutics, Inc.
- Ashok Bhandari
- G01 - MEASURING TESTING
Information Patent Application
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...
- Publication number 20180079782
- Publication date Mar 22, 2018
- Protagonist Therapeutics, Inc.
- Ashok Bhandari
- G01 - MEASURING TESTING
Information Patent Application
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...
- Publication number 20180022778
- Publication date Jan 25, 2018
- Protagonist Therapeutics, Inc.
- Gregory Bourne
- G01 - MEASURING TESTING
Information Patent Application
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...
- Publication number 20160145306
- Publication date May 26, 2016
- Protagonist Therapeutics, Inc.
- Gregory Thomas Bourne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Xiaoli Cheng

Person

Patents Grantslast 30 patents

Compositions of peptide inhibitors of Interleukin-23 receptor

Oral peptide inhibitors of interleukin-23 receptor and their use to...

Oral peptide inhibitors of interleukin-23 receptor and their use to...

Peptide inhibitors of interleukin-23 receptor and their use to trea...

Oral peptide inhibitors of interleukin-23 receptor and their use to...

Oral peptide inhibitors of interleukin-23 receptor and their use to...

Oral peptide inhibitors of interleukin-23 receptor and their use to...

Oral peptide inhibitors of interleukin-23 receptor and their use to...

Patents Applicationslast 30 patents

COMPOSITIONS OF PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR

ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...

Methods for Treating Inflammatory Bowel Diseases with alpha4beta7 I...

ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...

ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...

PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREA...

PEPTIDE INHIBITORS OF INTERLEUKIN-23 AND THEIR USE TO TREAT INFLAMM...

ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...

ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...

ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...

ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO...